Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.40 | N/A |
| PEG Ratio (TTM) | -3.52 | N/A |
| P/S Ratio (TTM) | 2.52 | N/A |
| P/B Ratio (TTM) | 1.06 | N/A |
| P/FCF Ratio (TTM) | 7.04 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.19 | N/A |
| Price to 5YR AVG FCF Ratio | 12.27 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.67% | N/A |
| ROE (TTM) | 6.18% | N/A |
| Net Profit Margin (TTM) | 14.39% | N/A |
| ROIC 5YR AVG | 10.28% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 128.10% | 19.26% | 8.96% |
| Revenue | 1.77% | 6.01% | 4.39% |
| Net Income | 124.74% | 26.21% | 13.24% |
| Cash Flow | 274.94% | 16.08% | -2.69% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.74 | N/A |
| Quick Ratio (TTM) | 1.74 | N/A |
| D/E Ratio (TTM) | 0.28 | N/A |
| Interest Coverage (TTM) | 0.70 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.71 | N/A |
| LTL to 5YR AVG FCF | 1.77 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.54% | N/A |